The Pharmaceuticals division is focused on the following areas: Cardiovascular, Oncology & Hematology, Women's Healthcare, and Ophthalmology.
The Business Unit Cardiovascular markets an oral anticoagulant for stroke prevention in atrial fibrillation, a form of arrhythmia, and other treatments for common cardiovascular disorders, including hypertension and dyslipidemia.
The Business Unit Oncology & Hematology supports treatments in areas requiring advanced expertise by focusing on anticancer agents and a treatment for hemophilia, recombinant human factor VIII.
The Business Unit Women's Health & Established Products provides medications that improve the quality of life for women for different life stages, including a treatment for dysmenorrhea and a low-dose oral contraceptive. At the same time, it markets and manages established products-which are not sold through MRs.
The Business Unit Ophthalmology offers treatments for retinal disorders such as wet age-related macular degeneration-a disease on the rise in Japan and western countries-helping to protect the vision of patients so that they can continue to enjoy a high quality of life.
The Business Unit Radiology supplies a diverse product lineup that includes contrast media, injectors, and related accessories for diagnostic imaging by X-ray, computed tomography (CT), magnetic resonance imaging (MRI) and ultrasound.
|Pharmaceuticals||Xarelto® (selective direct Factor Ⅹa inhibitor)|
|Zetia® Tablet 10mg (antihyperlipidemia)|
|ATOZET® Combination Tablets LD/HD (intestinal Cholesterol Transporter Inhibitor / HMG-CoA Reductase Inhibitor Combination Tablets)|
|Fosrenol® (hyperphosphatemia agent)|
|Adalat® (antihypertensive and angina pectoris agent)|
|Bayaspirin® 100mg (antiplatelet)|
|Adempas® (soluble guanylate cyclase stimulator)|
|Nexavar® 200mg (anticancer agent)|
|Stivarga® 40mg (anticancer agent)|
|Xofigo® (anticancer agent)|
|Kogenate®-FS BIO-SET (recombinant factor Ⅷ)|
|Kovaltry® for iv injection (recombinant factor Ⅷ)|
|EYLEA® solution for IVT inj. 40mg/mL (intravitreal VEGF inhibitor)|
|YAZ® (oral progestogen/estrogen combination for treatment of dysmenorrhea)|
|Yaz Flex® (therapeutic agent for treatment of pain associated with endometriosis/dysmenorrhea)|
|Triquilar® (oral contraceptive)|
|LEVITRA® (erectile dysfunction treatment)|
|BETAFERON® SC inj. (genetical recombinant interferon-beta-1b preparation)|
|Iopamiron® Inj. (non-ionic contrast medium for CT, angiography and urography)|
|EOB･Primovist® Inj. (MRI liver contrast agent)|
|Gadovist® IV Inj. 1.0mol/L (non-ionic MRI contrast agent)|
|Avanta (cardiovascular injection system)|
|Mark 7 Arterion (angio injection system)|
|Stellant D (CT injection system)|
|Salient (CT injection system)|
|Spectris Solaris EP (MR injection system)|
|Radimetrics (radiation dose management system)|
As of June, 2018